StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
28
This year
5
Publishing Date
2024 - 03 - 14
1
2024 - 02 - 26
1
2024 - 02 - 12
1
2024 - 01 - 16
2
2023 - 08 - 30
1
2023 - 08 - 02
1
2023 - 06 - 12
1
2023 - 06 - 05
1
2023 - 05 - 09
1
2023 - 04 - 04
1
2022 - 11 - 29
1
2022 - 11 - 10
1
2022 - 09 - 29
1
2022 - 09 - 19
1
2022 - 09 - 09
1
2022 - 07 - 25
1
2022 - 03 - 01
1
2021 - 12 - 22
1
2021 - 11 - 30
1
2021 - 10 - 25
1
2021 - 10 - 24
1
2021 - 06 - 07
1
2021 - 05 - 24
1
2021 - 03 - 30
1
2021 - 03 - 23
1
2021 - 03 - 01
1
2020 - 12 - 22
1
Sector
Health technology
28
Tags
Ak006
6
Ak007
1
Atopic dermatitis
1
Biotech-bay
1
Biotechnology
1
Business
2
Cell
4
Clinical trials
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
2
Communications
1
Dermatitis
2
Disease
3
Ema
1
Enroll
1
Expansion
1
Financial
2
Financial results
2
Gastrointestinal
2
Growth
2
Immunology
1
Immunotherapy
1
Ipo
1
Life science
1
Market
2
Meeting
1
Money
2
N/a
20
Offering
1
Pharmaceuticals
1
Phase 2
2
Phase 2/3
2
Phase 3
2
Preclinical
3
Presentation
3
Publication
2
Report
1
Results
4
Study
1
Test
2
Topline
2
Trial
1
Trials
1
Update
2
Urticaria
4
Year
1
Entities
3m company
938
Abb ltd
1427
Abbott laboratories
1787
Abbvie inc.
1024
Accenture plc
600
Alphabet inc.
1288
Amgen inc.
742
Apple inc.
1198
Arcelormittal
589
Arrival
4294
Astrazeneca plc
665
Bank of montreal
539
Becton, dickinson and company
796
Bnp paribas
1764
Boston scientific corporation
575
Bristol-myers squibb company
662
Broadcom inc.
593
Cisco systems, inc.
897
Cummins inc.
542
Danaher corporation
785
Dell technologies inc.
576
Dow inc.
556
Eli lilly and company
1709
Ericsson
1612
Extreme networks, inc.
581
First bank
598
Ford motor company
641
Gartner, inc.
594
General electric company
917
Glaxosmithkline plc
885
Honeywell international inc.
1787
Hubspot, inc.
1400
Intel corporation
955
International business machines corporation
655
Johnson & johnson
4583
Kering
1129
Koninklijke philips n.v.
962
Lithium corp
971
Live nation entertainment, inc.
717
Lockheed martin corporation
575
Medtronic plc
1285
Microsoft corporation
1201
Morgan stanley
4286
Nokia corp
975
Nokia corporation
901
Northrop grumman corporation
589
Novartis ag
1241
Novo nordisk a/s
632
Oracle corporation
1158
Orange
7191
Panasonic corp
650
Pfizer, inc.
692
Sanofi
4539
Sap se
1477
Snowflake inc.
796
Stryker corporation
536
Teva pharmaceutical industries ltd
631
Thermo fisher scientific inc
1622
Verizon communications inc.
1213
X financial
676
Symbols
ALLK
28
ASLN
1
EQ
1
GLAXF
2
GSK
2
ISRG
1
KDNY
1
KRYS
1
MIRM
1
NVS
2
NVSEF
2
REGN
1
SNY
3
SNYNF
3
SPRB
1
TBIO
1
TEVJF
2
VTRS
2
Exchanges
Nasdaq
28
Nyse
2
Crawled Date
2024 - 03 - 14
1
2024 - 02 - 26
1
2024 - 02 - 12
1
2024 - 01 - 16
2
2023 - 08 - 30
1
2023 - 08 - 02
1
2023 - 06 - 12
1
2023 - 06 - 05
1
2023 - 05 - 09
1
2023 - 04 - 04
1
2022 - 11 - 29
1
2022 - 11 - 10
1
2022 - 09 - 29
1
2022 - 09 - 19
1
2022 - 09 - 09
1
2022 - 07 - 26
1
2022 - 03 - 01
1
2021 - 12 - 22
1
2021 - 11 - 30
1
2021 - 10 - 25
1
2021 - 10 - 24
1
2021 - 06 - 07
1
2021 - 05 - 24
1
2021 - 03 - 30
1
2021 - 03 - 23
1
2021 - 03 - 01
1
2020 - 12 - 22
1
Crawled Time
00:00
1
01:00
1
09:00
1
11:00
2
12:00
5
12:20
1
13:00
2
13:03
1
15:00
1
16:00
1
17:00
1
18:00
1
19:00
1
20:00
4
20:20
1
22:00
3
23:00
1
Source
www.biospace.com
8
www.globenewswire.com
18
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
Previous years
entities :
Allakos inc.
save search
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 20:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-19.54%
|
O:
-1.15%
H:
2.33%
C:
1.55%
business
year
update
financial
results
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
Published:
2024-02-26
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-22.79%
|
O:
2.21%
H:
10.07%
C:
5.04%
ak006
cell
preclinical
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
Published:
2024-02-12
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-21.64%
|
O:
1.49%
H:
10.29%
C:
2.21%
ak006
publication
cell
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
Published:
2024-01-16
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-64.88%
|
O:
-59.2%
H:
10.66%
C:
-2.46%
urticaria
dermatitis
trials
Allakos Announces a Restructuring to Focus on Development of AK006
Published:
2024-01-16
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-64.88%
|
O:
-59.2%
H:
10.66%
C:
-2.46%
ak006
Allakos Appoints Neil Graham to its Board of Directors
Published:
2023-08-30
(Crawled : 20:00)
- globenewswire.com
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
7.93%
|
O:
0.11%
H:
0.0%
C:
-1.12%
ASLN
|
$0.54
0.0%
26K
|
Health Technology
|
-76.59%
|
O:
1.9%
H:
0.93%
C:
-0.7%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-64.16%
|
O:
1.02%
H:
5.17%
C:
-2.7%
Allakos Appoints Rand Sutherland and Dolca Thomas to its Board of Directors
Published:
2023-08-02
(Crawled : 20:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.05%
|
O:
-1.6%
H:
0.11%
C:
0.11%
TBIO
|
News
|
$0.302
-8.76%
-9.6%
160K
|
Health Technology
|
-70.41%
|
O:
-0.69%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.72%
|
O:
-3.79%
H:
0.0%
C:
0.0%
KRYS
|
$158.63
-3.26%
-3.37%
340K
|
Health Technology
|
31.5%
|
O:
-2.31%
H:
0.73%
C:
-1.14%
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
146.67%
|
O:
9.59%
H:
7.68%
C:
-6.75%
KDNY
|
$40.39
0.22%
-0.17%
0
|
Health Technology
|
0.5%
|
O:
0.02%
H:
0.26%
C:
0.22%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-80.87%
|
O:
-0.91%
H:
1.84%
C:
-1.1%
Allakos Presents Preclinical Data at EAACI Hybrid Congress 2023 Highlighting Lirentelimab and AK006 Mechanisms of Mast Cell Inhibition
Published:
2023-06-12
(Crawled : 11:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-78.13%
|
O:
0.0%
H:
5.21%
C:
2.71%
ak006
cell
preclinical
Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023
Published:
2023-06-05
(Crawled : 11:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-80.0%
|
O:
0.0%
H:
0.95%
C:
-2.29%
ak006
presentation
cell
immunology
Allakos Provides Business Update and Reports First Quarter 2023 Financial Results
Published:
2023-05-09
(Crawled : 20:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-75.64%
|
O:
0.46%
H:
5.54%
C:
-0.92%
business
update
financial
results
Urticaria Drugs Market size to grow by USD 1.31 billion from 2021 to 2026, Driven by the growth in incidence of urticaria - Technavio
Published:
2023-04-04
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
12.79%
|
O:
1.79%
H:
3.07%
C:
3.07%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.15%
|
O:
0.69%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
21.22%
|
O:
1.57%
H:
1.01%
C:
0.96%
VTRS
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
16.68%
|
O:
-0.1%
H:
3.15%
C:
2.94%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-0.43%
|
O:
1.29%
H:
0.83%
C:
0.4%
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
8.34%
|
O:
1.2%
H:
1.32%
C:
1.24%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.27%
|
O:
1.58%
H:
0.0%
C:
0.0%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-74.88%
|
O:
-0.96%
H:
1.21%
C:
-0.24%
urticaria
growth
market
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology
Published:
2022-11-29
(Crawled : 12:20)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-85.73%
|
O:
0.54%
H:
9.19%
C:
7.3%
ak006
communications
publication
Allakos Presents Preclinical Data on AK007, a Siglec-10 Antagonist Antibody, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting
Published:
2022-11-10
(Crawled : 16:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-84.23%
|
O:
3.6%
H:
2.17%
C:
2.17%
ak007
preclinical
immunotherapy
meeting
USD 1.31 Bn growth for Urticaria Drugs Market through 2026: Analysing growth for Pharmaceuticals - Technavio
Published:
2022-09-29
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
33.95%
|
O:
-3.32%
H:
4.73%
C:
4.73%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
22.25%
|
O:
0.22%
H:
0.33%
C:
0.33%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
51.07%
|
O:
1.87%
H:
0.0%
C:
0.0%
VTRS
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
27.38%
|
O:
-1.26%
H:
0.7%
C:
-0.23%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
21.96%
|
O:
0.17%
H:
1.1%
C:
0.16%
GSK
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
34.42%
|
O:
-0.14%
H:
0.53%
C:
-0.2%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
20.43%
|
O:
-0.13%
H:
0.0%
C:
0.0%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-81.8%
|
O:
-2.77%
H:
2.14%
C:
-0.18%
pharmaceuticals
urticaria
growth
market
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
Published:
2022-09-19
(Crawled : 13:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-77.07%
|
O:
16.59%
H:
14.79%
C:
9.36%
offering
Allakos Announces Topline Phase 3 Data from the EoDyssey Study in Patients with Eosinophilic Duodenitis
Published:
2022-09-09
(Crawled : 22:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-77.37%
|
O:
-8.41%
H:
18.12%
C:
15.41%
topline
study
Allakos Announces the Appointment of Dr. Amy Ladd to its Board of Directors
Published:
2022-07-25
(Crawled : 00:00)
- biospace.com/
ISRG
|
News
|
$366.1
-1.75%
-1.78%
3.8M
|
Health Technology
|
75.33%
|
O:
0.64%
H:
4.03%
C:
2.8%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-72.8%
|
O:
-0.26%
H:
0.71%
C:
-4.42%
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published:
2022-03-01
(Crawled : 23:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-80.7%
|
O:
-2.02%
H:
7.5%
C:
4.5%
financial results
report
results
Allakos Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data from the KRYPTOS Study in Patients with Eosinophilic Gastrointestinal Diseases
Published:
2021-12-22
(Crawled : 01:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-98.76%
|
O:
-87.46%
H:
2.55%
C:
-19.19%
phase 2
phase 2/3
gastrointestinal
disease
test
topline
phase 3
Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma
Published:
2021-11-30
(Crawled : 15:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-98.67%
|
O:
-0.92%
H:
0.0%
C:
0.0%
atopic dermatitis
expansion
dermatitis
urticaria
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
News
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.